Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors Invitation to the ordinary general shareholders meeting Biotalys Reports Full-Year 2025 Financial Results and Business Highlights Erste Zulassung in Florida: Vorsicht Bayer & BASF - Biologische Pflanzenschutzmittel rücken ins Rampenlicht! Biotalys Achieves First U.S. State Registration for EVOCA in Florida Biotalys Achieves First Milestone in Bioinsecticide Partnership with Syngenta Biotalys Announces New Dates for the Publication of its 2025 Annual Report and for its Annual Shareholders Meeting Biotalys Announces Changes to its Board of Directors and Executive Committee Biotalys Notice of Publication 2025 Annual Report and Financial Results Biotalys Announces Intention to Strategically Refocus its Activities to Prioritize Lead Assets and Reduce Annual Cash Burn Biotalys and 21st.BIO Enter into Strategic Partnership to Advance Biocontrol Production Biotalys Receives Regulatory Approval by U.S. EPA for EVOCA EPA Issues Proposed Registration Decision for Biotalys’ EVOCA™ Biofungicide Regulated information Biotalys Reports Half-Year 2025 Financial Results and Business Highlights